Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/44
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring > Polynucleotide (e.g., rna, dna, etc.)

Patents under this class:

Patent Number Title Of Patent Date Issued
7538095 Genetic inhibition by double-stranded RNA May. 26, 2009
7538083 Compositions and methods for the potentiation of immune responses against target antigens May. 26, 2009
7534775 Methods and compositions for modulating cardiac contractility May. 19, 2009
7534774 Traversal of nucleic acid molecules through a fluid space and expression in repair cells May. 19, 2009
7534773 TRPM-2 antisense therapy May. 19, 2009
7534772 Methods for enhancing antibody-induced cell lysis and treating cancer May. 19, 2009
7534769 Compositions and methods for enhancing delivery of therapeutic agents to cells May. 19, 2009
7534613 Methods of treating parkinson's disease using viral vectors May. 19, 2009
7531524 Modulators of coagulation factors with enhanced stability May. 12, 2009
7531523 Sodium channel protein type III alpha-subunit splice variant May. 12, 2009
7531522 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi May. 12, 2009
7531500 Preventing airway mucus production by administration of EGF-R antagonists May. 12, 2009
7531304 Method for screening FGFR-4 agonists May. 12, 2009
7531182 Vaccine against foot-and-mouth disease May. 12, 2009
7528118 RNAi modulation of ApoB and uses thereof May. 5, 2009
7528117 High efficacy antisense RI.sub..alpha.PKA poly-DNP oligoribonucleotides May. 5, 2009
7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis May. 5, 2009
7528106 Compositions and methods for treatment of neovascular diseases May. 5, 2009
7527800 Influenza hemagglutinin and neuraminidase variants May. 5, 2009
7525011 Transgenic cancer models in fish Apr. 28, 2009
7524872 Method and composition for treating cancer using cellular organelle crystallizing agents Apr. 28, 2009
7524830 Decoy-containing pharmaceutical compositions and method of using the same Apr. 28, 2009
7524829 Antisense antiviral compounds and methods for treating a filovirus infection Apr. 28, 2009
7524828 Immunostimulatory nucleic acid molecules Apr. 28, 2009
7524827 Methods and compositions for the inhibition of gene expression Apr. 28, 2009
7524826 Method of inhibiting the generation of active thrombin on the surface of a cell within an atherosclerotic plaque Apr. 28, 2009
7524675 Pharmaceutical use of alpha antigen or alpha antigen gene Apr. 28, 2009
7524674 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals Apr. 28, 2009
7524510 Alkyl-glycoside enhanced vaccination Apr. 28, 2009
7524490 Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site Apr. 28, 2009
7521431 Compositions and methods for siRNA inhibition of HIF-1 alpha Apr. 21, 2009
7521239 Photochemical internalization for virus-mediated molecule delivery into the cyosol Apr. 21, 2009
7521191 siRNA targeting connexin 43 Apr. 21, 2009
7521063 Multiple CPG oligodeoxynucleotides and their use to induce an immune response Apr. 21, 2009
7521043 Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines Apr. 21, 2009
7517866 LIM mineralization protein splice variants Apr. 14, 2009
7517865 RNAi modulation of RSV and therapeutic uses thereof Apr. 14, 2009
7517864 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) Apr. 14, 2009
7517863 Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide Apr. 14, 2009
7517862 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends Apr. 14, 2009
7517861 Immunostimulatory nucleic acid molecules Apr. 14, 2009
7517860 Inhibition of lipoprotein secretion Apr. 14, 2009
7517683 HIV-like particles and the use thereof Apr. 14, 2009
7517644 Method and compositions for cellular reprogramming Apr. 14, 2009
7517538 Solid supports functionalised with phosphorus dendrimers, method for preparing same and uses thereof Apr. 14, 2009
7514595 Targeted and regional cellular ablation in zebrafish Apr. 7, 2009
7514416 Interferon alpha and antisense K-ras RNA combination gene therapy Apr. 7, 2009
7514415 Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides Apr. 7, 2009
7514414 Suppressors of CpG oligonucleotides and methods of use Apr. 7, 2009
7514098 Use of targeted cross-linked nanoparticles for in vivo gene delivery Apr. 7, 2009

  Recently Added Patents
Adhering composition and method of applying the same
Data storage apparatus, memory control apparatus and method for controlling flash memories
System and method for providing definitions
Low cost mesh network capability
Crosslinked core/shell polymer particles
Protocol delay measuring device and protocol delay measuring method
Power generating apparatus of renewable energy type and method of attaching and detaching blade
  Randomly Featured Patents
Method and apparatus for processing and displaying videotext or telephone data
Surroundless loudspeaker
Insulated beverage box for golf carts
Slide rule cursor
Radial line slot antenna
Two-dimensional driving apparatus and method
EMI reduction for a flat-panel display controller using horizontal-line-based spread spectrum
Multimedia player component object system
Direct digital frequency synthesizer using hybrid digital to analog converter and synthesizing method thereof
Hybrid cross axis ball joint bushing